Form 8-K - Current report:
SEC Accession No. 0001104659-22-039671
Filing Date
2022-03-30
Accepted
2022-03-30 07:29:06
Documents
14
Period of Report
2022-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2210700d1_8k.htm   iXBRL 8-K 26685
2 EXHIBIT 99.1 tm2210700d1_ex99-1.htm EX-99.1 45224
6 GRAPHIC tm2210700d1_ex99-1img001.jpg GRAPHIC 8394
  Complete submission text file 0001104659-22-039671.txt   265324

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cgtx-20220330.xsd EX-101.SCH 3024
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgtx-20220330_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgtx-20220330_pre.xml EX-101.PRE 22589
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2210700d1_8k_htm.xml XML 3603
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40886 | Film No.: 22783123
SIC: 2836 Biological Products, (No Diagnostic Substances)